Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124916) titled 'A Single-Center, Single-Blind, Randomized Controlled Study on the Analgesic Effect of Scalp Nerve Block with Liposomal Bupivacaine After Craniotomy' on May 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Acute pain after craniotomy
Intervention:
Control group:Scalp nerve block with 0.5% bupivacaine hydrochloride
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-30
Target Sample Size: Control group:70;Experimental group:70;
Countries of Recruitment:
China
...